REGN - Regeneron Pharmaceuticals beats top-line and bottom-line estimates; initiates FY24 outlook February, 02 2024 06:32 AM Regeneron Pharmaceuticals Inc. 2024-02-02 06:32:56 ET More on Regeneron Pharmaceuticals Why I Expect Regeneron To Keep Delivering For Investors In 2024 (Upgrade) 2seventy stock rises as Regeneron acquires R&D assets For further details see: Regeneron Pharmaceuticals beats top-line and bottom-line estimates; initiates FY24 outlook